Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;7(2):95-102.
doi: 10.15420/aer.2018.22.2.

Pacing for Vasovagal Syncope

Affiliations
Review

Pacing for Vasovagal Syncope

Rakesh Gopinathannair et al. Arrhythm Electrophysiol Rev. 2018 Jun.

Abstract

Vasovagal syncope (VVS) is due to a common autonomic reflex involving the cardiovascular system. It is associated with bradycardia (cardioinhibitory response) and/or hypotension (vasodepressor response), likely mediated by parasympathetic activation and sympathetic inhibition. While generally a situational, isolated and/or self-limited event, for some, VVS is recurrent, unpredictable and debilitating. Conservative, non-pharmacological management may help, but no specific medical therapy has been proven widely effective. Permanent pacing may have specific benefit, but its value has been debated. The temporal causative association of bradycardia with syncope in those with VVS may help identify which patient could benefit from pacing but the timing and type of pacing in lieu of blood pressure changes may be critical. The mode, rate, pacing algorithm and time to initiate dual-chamber pacing preferentially with respect to the vasovagal reflex may be important to prevent or ameliorate the faint but completely convincing data are not yet available. Based on available data, DDD pacing with the closed loop stimulation algorithm appears a viable, if not the best, alternative presently to prevent recurrent VVS episodes. While several knowledge gaps remain, permanent pacing appears to have a role in managing select patients with VVS.

Keywords: Syncope; asystole; closed loop stimulation; pacing; rate drop response; vasovagal syncope.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Rakesh Gopinathannair has received consultant/speaker fees from Abbott, the American Heart Association, Pfizer, Bristol Myers Squibb and Zoll, and is on the advisory board of HealthTrust PG. Brian Olshansky has received consultant/speaker fees from Amarin Corporation, Boehringer Ingelheim, Cryolife and Lundbeck. Benjamin Salgado has no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Example of a Typical Vasovagal Reflex
Figure 2:
Figure 2:. Hypotension and Bradycardia in Vasovagal Syncope
Figure 3:
Figure 3:. Asystole in Recurrent Syncope
Figure 4:
Figure 4:. Pathophysiological Mechanisms in VVS Leading to Bradycardia and Hypotension, Role of Pacing and Currently Used Pacing Algorithms
Figure 5:
Figure 5:. Asystolic Spell During a Vasovagal Episode
Figure 6:
Figure 6:. Ventricular Pacing During Head-up Tilt Testing
Figure 7:
Figure 7:. Syncopal Episode During Head-up Tilt-table Testing
Figure 8:
Figure 8:. Severe Bradycardia and Asystole

References

    1. Lewis T. A Lecture on vasovagal syncope and the carotid sinus mechanism. BMJ. 1932;1:873–6. doi: 10.1136/bmj.1.3723.873. - DOI - PMC - PubMed
    1. Brignole M, Alboni P, Benditt DG et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Eur Heart J. 2004;25:2054–72. doi: 10.1016/].ehj.2004.09.004. - DOI - PubMed
    1. Moya A. Tilt testing and neurally mediated syncope: too many protocols for one condition or specific protocols for different situations? Eur Heart J. 2009;30:2174–6. doi: 10.1093/eurheart]/ehp290. - DOI - PubMed
    1. Linzer M, Pontinen M, Gold DT et al. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44:1037–43. doi: 10.1016/0895-4356(91)90005-T. - DOI - PubMed
    1. Soteriades ES, Evans JC, Larson MG et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–85. doi: 10.1056/NEJMoa012407. - DOI - PubMed